IITDLogo
The Ethics of Intellectual Property Rights and Patents

International Bioethical Conference

The Ethics of Intellectual Property Rights and Patents

April 23-24, 2004, Warsaw


Held under the auspices of the Secretary General, Council of Europe, and the Minister of Science and the Minister of Health, Poland
in cooperation with Association of Pharmaceutical Companies Representatives in Poland
and the European Forum for Good Clinical Practice



The letter from The President of the Republic of Poland to the participants and organizers of the 5th International Conference on Bioethics "The Ethics of Intellectual Property Rights and Patents"
Polish original

Conference pictures

Speakers

  • An Baeyens, European Commission, Unit Ethics and Science, Brussels, Belgium,
    Intellectual Property Rights and Patents - Ethical Issues From an European Union Perspective


  • Harvey Bale, Director General, International Federation of Pharmaceutical Manufacturers Association, Geneva, Switzerland,
    Industry, Innovation and Social Values

  • Cathy Garner, CEO, The Centre for the Management of Intellectual Property in Health, R&D, London, UK,
    Addressing Health Inequities through the Creative Management of Intellectual Property

  • Richard Gold, Centre for Intellectual Property Policy, Mc Gill University, Montreal, Canada,
    The Ethical Consequences of Patent Rights, Especially in Developing Countries

  • Francis Gurry, Assistant Director General, Legal Counsel,
    World Intellectual Property Organization, Geneva, Switzerland,
    Public Policy and the Development of the International Patent System

  • William B. Hurlbut, M.D., Stanford University,
    Member, The (US) President's Council on Bioethics,
    Patenting Human Life: Clones, Chimeras and Technological Artifacts

  • Ioana Ispas, European Integration Counsellor, Ministry Of Education, Research And Youth, Bucharest, Romania
    Is Gene Patenting Beneficial to Science?

  • Brigitte E.S. Jansen, Director, European Academy for Environment and Economy, Lueneburg, Germany,
    Discussion on Patenting in Germany: Ethical and Legal Aspects

  • Agnieszka Jankowska, M.A. Int.Economics, Akonsult - Business Development through Licensing, Rheinfelden, Switzerland,
    Making technology broadly available - pro's and con's of licensing programs

  • Ingwer Koch, Director, Directorate Patent Law, European Patent Office, Munich, Germany,
    Patent Law, Ethics and Biotechnology

  • Wlodzimierz Kubiak, President, Association of Pharmaceutical Companies Representatives in Poland,
    Medicine and pharmacy: Fact and fiction about the development of innovation in Poland

  • Franz Porzsolt, Department of Clinical Economy, University of Ulm, Germany,
    Intellectual Property and Intellectual Responsibility of Scientific Fraud

  • Judit Sandor, Central European University, Budapest,
    Duality of the Legal Norms on Genes: Human Rights and Property Law

  • Tomasz Sieniow, LL.M., Chair of European Law, Law Faculty, Catholic University of Lublin, Poland,
    Parallel Importation of Patented Goods - The Developed World's Position

  • Alyna C. Smith, Ethics Officer, Human Genetics Programme, World Health Organization, Geneva, Switzerland,
    The Ethics of Genetic Patents: the Perspective of the WHO

  • Anthony D. So, MD, MPA, Director, Program on Global Health and Technology Access, Duke University,
    Ensuring Research Access to the Building Blocks of Knowledge

  • Anne G.K. Solomon, Director, Biotechnology and Public Policy Program, Center for Strategic and International Studies, Washington, DC 20006,
    Knowledge Wars: the Geopolitical Impact of Intellectual Property Rights Confrontations

  • Jacek Splawinski, National Institute of Public Health, Warsaw,
    The Complex Paths of Ethics: the Story of Obstetrical Forceps

  • Sigrid Sterckx, Ghent University, Dept. of Philosophy & Moral Science, Ghent;
    University of Antwerp, Dept. of General Economics, Antwerp, Belgium,
    Can Drug Patents Be Morally Justified?

  • Zbigniew Szawarski, University of Warsaw, Poland,
    Ethics and the "Gag Clause"

  • Sandy Thomas, Director, Nuffield Council on Bioethics, London, UK,
    The Ethics of Patenting DNA

  • Jan Wahlstroem, Professor, Sahlgren's Hospital, Gothenburg; Swedish Council of Ethics in Medicine,
    Swedish Opposition Against EU - Patent Directive

  • John R. Williams, Director of the Ethics Unit, World Medical Association,
    The Ethics Activities of the World Medical Association

  • Rafal Witek, Witek, Twardowska & Sniezko, Patent Attorneys, Warsaw; Patent Adviser, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw,
    Ethics and Patentability in Biotechnology

  • Paweł Wlasienko, Student and member of the Senate Committee on Teaching, The Medical University of Warsaw,
    Ethical and Legal Aspects of Teaching Students of Medicine

  • Franz Josef Zimmer, Grunecker, Kinkeldey Stockmair & Schwanhausser, Munich, Germany,
    The Immoral Gene: Does it Really Exist?

 

Special session

Improving the Public's Trust in Human Research: The Need for Human Subjects Protections

Under the patronage of the Medical Division of the Polish Academy of Sciences

Chair: Professor John R. Williams, World Medical Association
   

  • Keynote Speaker:
    Marjorie A. Speers, Ph.D., Executive Director, Association for the Accreditation of Human Research Protection Programs*, Washington, DC,
    Making Research Safe: Why We Can't Afford to Fail
    *founded by: American Association of Medical Colleges, American Association of Universities, Federation of American Societies for Experimental Biology, National Health Council

  • Francis P. Crawley, Secretary General & Ethics Officer, European Forum for Good Clinical Practice,
    The Responsibilities of the European Sponsor and Researcher Toward Patients, Communities, & Public Health: Questions of Equity Regarding Intellectual Property in Sharing the Benefits of Research and Providing Access to Medicines

  • Melody Lin, Ph.D., Deputy Director / Director - International Activities,
    Office for Human Research Protections,
    U.S. Department of Health and Human Services,
    How the United States Conduct Human Research Ethically

  • Andrzej Rzeplinski, Helsinki Foundation for Human Rights/University of Warsaw

  • Tadeusz Tolloczko, Former Rector, The Medical University of Warsaw,
    Surgical Patents and Patients - The Ethical Dilemmas

Participants will receive 10 accreditation points in accordance with par. 6 item 1 of the resolution of 24 Jan. 2003 of the Supreme Medical Council (Poland)

Internet Patron : www.esculap.pl

Further information: www.iprap.website.pl